How India is vaccinating teenagers against Covid amid Omicron spread

On January 1, Union Health Minister Mansukh Mandaviya had requested people to register eligible children in their families

vaccine
A girl reacts as she receives a dose of Covaxin inside a classroom of a school, which has been converted into a temporary vaccination centre, during a vaccination drive for children aged 15-18 in New Delhi (Photo: Reuters)
IANS New Delhi
2 min read Last Updated : Jan 03 2022 | 4:42 PM IST

Amid rising Omicron cases, the Centre on Monday rolled out Covid vaccination for children aged 15-18. Over 4.5 lakh teenagers have, received their first jab against the infectious disease so far.

Last week, Prime Minister Narendra Modi had announced that Covid-19 vaccination for children between 15-18 years of age will be rolled out from January 3. According to official estimates, there are approximately 10 crore children in this age group.

On January 1, Union Health Minister Mansukh Mandaviya had requested people to register eligible children in their families.

Taking to Twitter, he said: "On the occasion of New Year, registration is being started on the CoWIN portal for immunisation of children against Covid-19 in the age group of 15 to 18 years from today. I request the family members to register the eligible children for vaccination."

Over 8,00,000 children have already registered for their dose in the past few days.

According to the guidelines, children can self-register online through an existing account on CoWIN or can also register by creating a new account through a unique mobile number or using their parent's accounts. Children can also get registered onsite by verifier or vaccinator; and they can walk in to take their shots.

Out of the 10 crore children eligible for the Covid vaccination, over 4.5 lakh teenagers have already received their first shots.

The vaccine used for inoculating children is Bharat Biotech's Covaxin, according to a set of new guidelines issued by the Union health ministry.

On December 24, the Drugs Controller General of India (DGCI), granted emergency use authorisation to the indigenously-developed Covaxin for children above 12 years of age.

Most of the schools and other educational institutions are being used as inoculation centres as well.

To avoid mixing-up of Covid vaccines for children and adults during administration, Mandaviya has also advised states and Union territories to make separate Covid vaccination centres (CVCs), separate session sites, separate queue (if adult vaccination is going on at the same centre) and separate immunisation team (if at same session site) for adults and children.

--IANS

rvt/sks/skp/

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :CoronavirusCoronavirus TestsCoronavirus Vaccine

First Published: Jan 03 2022 | 4:42 PM IST

Next Story